These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 33711473)

  • 1. Near Infrared Spectroscopy as a PAT tool for monitoring and control of protein and excipient concentration in ultrafiltration of highly concentrated antibody formulations.
    Thakur G; Hebbi V; Rathore AS
    Int J Pharm; 2021 May; 600():120456. PubMed ID: 33711473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Process analytical technology for on-line monitoring of quality attributes during single-use ultrafiltration/diafiltration.
    West JM; Feroz H; Xu X; Puri N; Holstein M; Ghose S; Ding J; Li ZJ
    Biotechnol Bioeng; 2021 Jun; 118(6):2293-2300. PubMed ID: 33666234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanistic model of pH and excipient concentration during ultrafiltration and diafiltration processes of therapeutic antibodies.
    Ladwig JE; Zhu X; Rolandi P; Hart R; Robinson J; Rydholm A
    Biotechnol Prog; 2020 Sep; 36(5):e2993. PubMed ID: 32185869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Theoretical analysis of excipient concentrations during the final ultrafiltration/diafiltration step of therapeutic antibody.
    Miao F; Velayudhan A; DiBella E; Shervin J; Felo M; Teeters M; Alred P
    Biotechnol Prog; 2009; 25(4):964-72. PubMed ID: 19569193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Small-Scale Process for Predicting Donnan and Volume Exclusion Effects During Ultrafiltration/Diafiltration Process Development.
    Abel J; Kosky A; Ball N; Bacon H; Kaushik R; Kleemann GR
    J Pharm Sci; 2018 May; 107(5):1296-1303. PubMed ID: 29339134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-time monitoring of quality attributes by in-line Fourier transform infrared spectroscopic sensors at ultrafiltration and diafiltration of bioprocess.
    Wasalathanthri DP; Feroz H; Puri N; Hung J; Lane G; Holstein M; Chemmalil L; Both D; Ghose S; Ding J; Li ZJ
    Biotechnol Bioeng; 2020 Dec; 117(12):3766-3774. PubMed ID: 32776504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A mechanistic model to account for the Donnan and volume exclusion effects in ultrafiltration/diafiltration process of protein formulations.
    Yu Z; Moomaw JF; Thyagarajapuram NR; Geng SB; Bent CJ; Tang Y
    Biotechnol Prog; 2021 Mar; 37(2):e3106. PubMed ID: 33289341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. pH and excipient profiles during formulation of highly concentrated biotherapeutics using bufferless media.
    Jabra MG; Tao Y; Moomaw JF; Yu Z; Hotovec BJ; Geng SB; Zydney AL
    Biotechnol Bioeng; 2020 Nov; 117(11):3390-3399. PubMed ID: 32667708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monitoring of ultra- and diafiltration processes by Kalman-filtered Raman measurements.
    Rolinger L; Hubbuch J; Rüdt M
    Anal Bioanal Chem; 2023 Feb; 415(5):841-854. PubMed ID: 36651972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting diafiltration solution compositions for final ultrafiltration/diafiltration steps of monoclonal antibodies.
    Teeters M; Bezila D; Benner T; Alfonso P; Alred P
    Biotechnol Bioeng; 2011 Jun; 108(6):1338-46. PubMed ID: 21328314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multi-attribute PAT for UF/DF of Proteins-Monitoring Concentration, particle sizes, and Buffer Exchange.
    Rolinger L; Rüdt M; Diehm J; Chow-Hubbertz J; Heitmann M; Schleper S; Hubbuch J
    Anal Bioanal Chem; 2020 Apr; 412(9):2123-2136. PubMed ID: 32072210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting Formulation Conditions During Ultrafiltration and Dilution to Drug Substance Using a Donnan Model with Homology-Model Based Protein Charge.
    Kannan A; Chinn M; Izadi S; Maier A; Dvornicky J; Fedesco M; Day E; Ladiwala A; Woys A
    J Pharm Sci; 2023 Mar; 112(3):820-829. PubMed ID: 36336103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strategies for high-concentration drug substance manufacturing to facilitate subcutaneous administration: A review.
    Holstein M; Hung J; Feroz H; Ranjan S; Du C; Ghose S; Li ZJ
    Biotechnol Bioeng; 2020 Nov; 117(11):3591-3606. PubMed ID: 32687221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Designing scalable ultrafiltration/diafiltration process of monoclonal antibodies via mathematical modeling by coupling mass balances and Poisson-Boltzmann equation.
    Ambrožič R; Arzenšek D; Podgornik A
    Biotechnol Bioeng; 2021 Feb; 118(2):633-646. PubMed ID: 33049074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Caffeine as a Viscosity Reducer for Highly Concentrated Monoclonal Antibody Solutions.
    Zeng Y; Tran T; Wuthrich P; Naik S; Davagnino J; Greene DG; Mahoney RP; Soane DS
    J Pharm Sci; 2021 Nov; 110(11):3594-3604. PubMed ID: 34181992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High performance liquid chromatography (HPLC) based direct and simultaneous estimation of excipients in biopharmaceutical products.
    Hebbi V; Chattopadhyay S; Rathore AS
    J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Jun; 1117():118-126. PubMed ID: 31005704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Process Analytical Technology (PAT) Implementation for Membrane Operations in Continuous Manufacturing of mAbs: Model-Based Control of Single-Pass Tangential Flow Ultrafiltration.
    Thakur G; Masampally V; Kulkarni A; Rathore AS
    AAPS J; 2022 Jul; 24(4):83. PubMed ID: 35831532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ranking mAb-excipient interactions in biologics formulations by NMR spectroscopy and computational approaches.
    Zhang C; Gossert ST; Williams J; Little M; Barros M; Dear B; Falk B; Kanthe AD; Garmise R; Mueller L; Ilott A; Abraham A
    MAbs; 2023; 15(1):2212416. PubMed ID: 37218059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NMR spectroscopy as a characterization tool enabling biologics formulation development.
    Ma J; Pathirana C; Liu DQ; Miller SA
    J Pharm Biomed Anal; 2023 Jan; 223():115110. PubMed ID: 36308923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of powder blend uniformity: Comparison of real-time NIR blend monitoring with stratified sampling in combination with HPLC and at-line NIR Chemical Imaging.
    Bakri B; Weimer M; Hauck G; Reich G
    Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):78-89. PubMed ID: 26455421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.